Lornoxicam Tablets Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 4 mg, 8 mg
Reference Brands: Xefo (EU)
Category: Analgesic
Lornoxicam inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis responsible for pain and inflammation. Benefits include rapid, effective relief from acute pain, inflammation, and rheumatologic conditions. It offers anti-inflammatory, analgesic effects with a favorable safety profile when used appropriately. Lornoxicam tablets is available in Oral Tablets and strengths such as 4 mg, 8 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lornoxicam tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Lornoxicam tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Lornoxicam tablets are approved in the EU for managing pain and inflammation, regulated by EMA with dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, lornoxicam is not approved and is not marketed. In the EU, brands like Xefo (by Orion) are supported by comprehensive clinical data, with ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for lornoxicam tablets, ensuring adherence to European standards for safe, effective pain management, helping you navigate complex regulatory pathways seamlessly.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lornoxicam is used to relieve pain, inflammation, and swelling in conditions such as osteoarthritis, rheumatoid arthritis, and postoperative or acute musculoskeletal pain.
Lornoxicam is made from the active ingredient lornoxicam, an oxicam-class non-steroidal anti-inflammatory drug (NSAID), along with standard pharmaceutical excipients based on the manufacturer’s formulation.
Common trade names include Xefo and Lornoxicam (regional branded generics).
Lornoxicam is manufactured by several pharmaceutical companies globally, including manufacturers in the EU, UK, and other regulated markets.
The generic name is lornoxicam.
Well-known brand names include Xefo and various regional branded generics.
It is manufactured in multiple countries worldwide, including regions across Europe, the UK, and other approved global pharmaceutical manufacturing locations.
Related Products
Methocarbamol
Strength:
500 mg, 750 mg
Form: Tablet / Injection
Reference Brands: Robaxin (USA/EU), Carbacot (USA/EU)
View Details
Meperidine Hydrochloride
Strength:
50 mg, 100 mg, 50 mg/5 mL
Form: Tablets/ Injectable / Oral Solution
Reference Brands: Demerol (USA)
View Details
Meclofenamate
Strength:
50 mg, 100 mg
Form: Tablets
Reference Brands: Meclomen (USA), Mecloflam (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
